Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 1,202

The world’s first portable brain computer interface (BCI) is being developed by Blackrock and University of Pittsburgh so patients can undergo research trials at home. Rapid Robotics releases fastest and easiest robotic arm setup in requiring no code at all. New AI using light performs 1,000x faster at classifying data.

AI News Timestamps:
0:00 First Portable Brain Computer Interface.
2:29 Rapid Robotics Fastest Robot Arm Setup.
5:03 New AI Using Light Is 1,000x Faster.

👉 Crypto AI News: https://www.youtube.com/c/CryptoAINews/videos.

#ai #robot #news

Read more | >

Reaching the golden years doesn’t always feel so golden. Growing older introduces a range of health challenges, including being at increased risk for developing chronic diseases and having reduced immunity to infection. But while scientists have traditionally viewed the unpleasant aspects of aging as inevitable, new research could reveal how to substantially delay aging and improve the health of older individuals.

Chronic inflammation, one of the major hallmarks of aging, is thought to be partly caused by senescent cells that may accumulate in older individuals. Now, Yale researchers have received a grant [U54-AG079759] from the National Institutes of Health (NIH) Common Fund’s Cellular Senescence Network Program (SenNet) to study these specialized cells. The grant will further scientists’ knowledge of the mechanisms behind aging and potential therapies for dampening inflammation associated with old age. The SenNet is based on ‘Geroscience,’ an approach that intersects basic aging biology, chronic disease, and health to understand the cellular mechanisms that make aging a major risk factor for common chronic conditions of older people. Support by the NIH Common Fund shows the NIH’s commitment to Geroscience as a complex, high priority topic in biomedical research.

“A number of diseases that increase in older people may have a unifying underlying mechanism having to do with senescence,” says Ruth Montgomery, PhD, professor of medicine and of epidemiology (microbial diseases), and co-PI of the project. “If we are able to understand and address this, we may be able to reduce the incidence of a number of diseases, including cancers and heart diseases.”

Read more | >

Discussion panel with:
- Swati Chavda, a science fiction writer and former brain surgeon.
- Ron S. Friedman, a science fiction writer and an Information Technologies Specialist.

August 13th 2022, When Words Collide festival.

#booktube #authortube #writingtube #braincomputerinterface #neuralink.

Relevant links:

Swati Chavda website: https://www.swatichavda.com/

Ron S. Friedman website: https://ronsfriedman.wordpress.com/

Continue reading “Brain — Computer Interface. How this new technology will change the word” | >

Cas13 variants with minimal collateral effect are expected to be more competitive for in vivo RNA editing and future therapeutic applications, researchers claim.

Scientists from the Chinese Academy of Sciences (CAS) have allegedly developed a new “controllable, reversible and safer” gene-editing approach using CRISPR technology.

The system, named Cas13D-N2V8, showed a significant reduction in the number of off-target genes and no detectable collateral damage in cell lines and somatic cells, which indicated its future potential, according to a report published in South China Morning Post newspaper on Wednesday.

Researchers from the Chinese Academy of Sciences say their technology uses an enzyme that targets RNA and has more short-lived effects.

Read more | >

If the combination of Covid-19 and remote work technologies like Zoom have undercut the role of cities in economic life, what might an even more robust technology like the metaverse do? Will it finally be the big upheaval that obliterates the role of cities and density? To paraphrase Airbnb CEO Brian Chesky: The place to be was Silicon Valley. It feels like now the place to be is the internet.

The simple answer is no, and for a basic reason. Wave after wave of technological innovation — the telegraph, the streetcar, the telephone, the car, the airplane, the internet, and more — have brought predictions of the demise of physical location and the death of cities.

Remote work has become commonplace since the beginning of the Covid-19 pandemic. But the focus on daily remote work arrangements may miss a larger opportunity that the pandemic has unearthed: the possibility of a substantially increased labor pool for digital economy work. To measure interest in digital economy jobs, defined as jobs within the business, finance, art, science, information technology, and architecture and engineering sectors, the authors conducted extensive analyses of job searches on the Bing search engine, which accounts for more than a quarter of all desktop searches in the U.S. They found that, not only did searches for digital economy jobs increase since the beginning of the pandemic, but those searches also became less geographically concentrated. The single biggest societal consequence of the dual trends of corporate acceptance of remote work and people’s increased interest in digital economy jobs is the potential geographic spread of opportunity.

Page-utils class= article-utils—vertical hide-for-print data-js-target= page-utils data-id= tag: blogs.harvardbusiness.org, 2007/03/31:999.334003 data-title= Who Gets to Work in the Digital Economy? data-url=/2022/08/who-gets-to-work-in-the-digital-economy data-topic= Business and society data-authors= Scott Counts; Siddharth Suri; Alaysia Brown; Brian Xu; Sharat Raghavan data-content-type= Digital Article data-content-image=/resources/images/article_assets/2022/08/Aug22_04_509299271-383x215.jpg data-summary=

The labor market for jobs you can do on a laptop is expanding beyond major cities.

Read more | >

Neuralink, a company co-founded by Elon Musk, has been working on an implantable brain-machine interface since 2016. While it previously demonstrated its progress by showing a Macaque monkey controlling the cursor.

It’s unclear what kind of deal Musk has offered — whether it’s a collaboration or a financial investment —since none of the players responded or confirmed the report with the news organization.

Elon Musk’s last update on Neuralink — his company that is working on technology that will connect the human brain directly to a computer — featured a pig with one of its chips implanted in its brain. Now Neuralink is demonstrating its progress by showing a Macaque with one of the Link chips playing Pong. At first using “Pager” is shown using a joystick, and then eventually, according to the narration, using only its mind via the wireless connection.

Today we are pleased to reveal the Link’s capability to enable a macaque monkey, named Pager, to move a cursor on a computer screen with neural activity using a 1,024 electrode fully-implanted neural recording and data transmission device, termed the N1 Link. We have implanted the Link in the hand and arm areas of the motor cortex, a part of the brain that is involved in planning and executing movements. We placed Links bilaterally: one in the left motor cortex (which controls movements of the right side of the body) and another in the right motor cortex (which controls the left side of the body).

In an accompanying blog post, Neuralink says it’s building on decades of research that developed systems connecting “a few hundred electrodes” that needed a physical connector through the skin, compared to its N1 Link with 1,024 electrodes. According to Neuralink, “Our mission is to build a safe and effective clinical BMI system that is wireless and fully implantable that users can operate by themselves and take anywhere they go; to scale up the number of electrodes for better robustness and higher information throughput; and to automate the implant surgery to make it as rapid and safe as possible.”

Read more | >

Were you unable to attend Transform 2022? Check out all of the summit sessions in our on-demand library now! Watch here.

I have been thinking about death lately. Not a lot — a little. Possibly because I recently had a month-long bout of Covid-19. And, I read a recent story about the passing of the actor Ed Asner, famous for his role as Lou Grant in “The Mary Tyler Moore Show.” More specifically, the story of his memorial service where mourners were invited to “talk” with Asner through an interactive display that featured video and audio that he recorded before he died. The experience was created by StoryFile, a company with the mission to make AI more human. According to the company, their proprietary technology and AI can match pre-recorded answers with future questions, allowing for a real-time yet asynchronous conversation.

In other words, it feels like a Zoom conversation with a living person.

Read more | >

Hui Li, PhD, a Department of Pathology researcher, along with his team discovered that a gene responsible for the deadliest type of brain tumor is also found to be responsible for two forms of childhood cancer. The new discovery may open the door to the first targeted treatments for two types of rhabdomyosarcoma, a cancer of the soft tissue that primarily strikes young children. Research also suggests the gene may play an important role in other cancers that form in muscle, fat, nerves and other connective tissues in both children and adults. Hui Li, PhD, and team published their findings in the scientific journal PNAS.

Read more | >

Christian Angermayer, founder of talks longevity investment, optimism on SPAC deal and light at the end of the tunnel for the biotech market.
One of the speakers at October’s Rejuvenation Startup Summit in Berlin is the entrepreneur and investor, Christian Angermayer.

With more than $3 billion under management through his Apeiron Investment Group, Angermayer is a major figure in the longevity sector through his platform biotech companies Cambrian and Rejuveron – building on his belief that everyone wants to live healthier, happier and longer lives.

Ahead of Berlin’s meeting, our editor-in-chief caught up with Angermayer for a video interview in which he shares his views on subjects ranging from longevity investing, the biotech market, and what’s happening with his $200 million SPAC with David Sinclair and Peter Attia.

Visit Longevity. Technology — https://bit.ly/3PwtH8Y

Follow Longevity. Technology on:
Twitter — https://bit.ly/3AMIXuq.
Facebook — https://bit.ly/3z8H1v5
Instagram — https://bit.ly/3IDvVRX
Linkedin — https://bit.ly/3yIfDmf

Read more | >